Evidence map›Paper›PMID 34843106›Full record

ArticleInternational journal of cancer2022

Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.

Talía Malagón, Jean H E Yong, Parker Tope, Wilson H Miller, Eduardo L Franco, McGill Task Force on the Impact of COVID-19 on Cancer Control and Care

Abstract read
In one paragraph

Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Advanced practice nurse-led early palliative care: a novel model for improved access to care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  16. Rising out-of-hospital mortality in Canada during 2020‒2022: A striking impact observed among young adults.Canadian journal of public health = Revue canadienne de sante publique · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Talía MalagónDivision of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-9505-3564
Jean H E YongCanadian Partnership Against Cancer, Toronto, Ontario, Canada.
Parker TopeDivision of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, Quebec, Canada.
Wilson H MillerDepartment of Oncology, McGill University, Montreal, Quebec, Canada.
Eduardo L FrancoDivision of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-4409-8084
McGill Task Force on the Impact of COVID-19 on Cancer Control and Care

Funding

Canada Foundation for Innovation (CFI)CIHR 143347CIHR VR5-172666Fonds de recherche du Québec - Nature et technologies (FRQ-NT)Ministère de l'Économie, des Sciences et de l'Innovation du Québec (MESI)
6 · The paper itself

Abstract

The COVID-19 pandemic has affected cancer care worldwide. This study aimed to estimate the long-term impacts of cancer care disruptions on cancer mortality in Canada using a microsimulation model. The model simulates cancer incidence and survival using cancer incidence, stage at diagnosis and survival data from the Canadian Cancer Registry. We modeled reported declines in cancer diagnoses and treatments recorded in provincial administrative datasets in March 2020 to June 2021. Based on the literature, we assumed that diagnostic and treatment delays lead to a 6% higher rate of cancer death per 4-week delay. After June 2021, we assessed scenarios where cancer treatment capacity returned to prepandemic levels, or to 10% higher or lower than prepandemic levels. Results are the median predictions of 10 stochastic simulations. The model predicts that cancer care disruptions during the COVID-19 pandemic could lead to 21 247 (2.0%) more cancer deaths in Canada in 2020 to 2030, assuming treatment capacity is recovered to 2019 prepandemic levels in 2021. This represents 355 172 life years lost expected due to pandemic-related diagnostic and treatment delays. The largest number of expected excess cancer deaths was predicted for breast, lung and colorectal cancers, and in the provinces of Ontario, Québec and British Columbia. Diagnostic and treatment capacity in 2021 onward highly influenced the number of cancer deaths over the next decade. Cancer care disruptions during the COVID-19 pandemic could lead to significant life loss; however, most of these could be mitigated by increasing diagnostic and treatment capacity in the short-term to address the service backlog.

Indexed as

COVID-19FemaleHumansIncidenceMaleNeoplasmsPandemicsSARS-CoV-2Survival AnalysisTime-to-Treatmentcancer mortalityCOVID-19decision modeltime to diagnosistime to treatment

Identifiers

PMID34843106
PMCPMC9015510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.